Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pieris Pharmaceuticals Inc
PIRSCurrent price
16.1 USD
-0.37 USD (-2.25%)
Last closed
16.12 USD
Company
www.pieris.com
ISIN
US7207951036
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
22 219 640 USD
Yield for 12 month
-19.50 %
1Y
3Y
5Y
10Y
15Y
PIRS
Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics immuno-oncology (IO) programs. Its clinical pipeline consists of IO bispecifics, including S095012 (PRS-344), a bispecific Mabcalin compound targeting PD-L1 and 4-1BB in partnership with Les Laboratoires Servier and Institut de Recherches Internationales Servier; SGN-BB228 (PRS-346), a CD228 x 4-1BB bispecific antibody-Anticalin compound targeting CD228 and 4-1BB in partnership with Pfizer Inc.; and BOS-342 (PRS-342), a GPC3 x 4-1BB bispecific Mabcalin compound targeting GPC3 and 4-1BB in partnership with Boston Pharmaceuticals, which are in phase 1 studies. The company was founded in 2001 and is headquartered in Boston, Massachusetts. Address: 225 Franklin Street, Boston, MA, United States, 02110
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
–Current Year
+42 810 000 USD
Last Year
+25 902 000 USD
Current Quarter
–
Last Quarter
+53 000 USD
Current Year
+1 009 000 USD
Last Year
+23 122 000 USD
Current Quarter
-751 000 USD
Last Quarter
+83 000 USD
Key Figures PIRS
1 year
3 years
5 years
10 years
EBITDA
-11 335 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.18 %
PEG Ratio
–
Return On Equity TTM
-80.46 %
Wall Street Target Price
7 USD
Revenue TTM
20 872 000 USD
Book Value
14.17 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-97.3 %
Dividend Yield
–
Gross Profit TTM
-27 080 000 USD
Earnings per share
-19.21 USD
Diluted Eps TTM
-19.21 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-114.12 %
Dividend Analytics PIRS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PIRS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:80
Payout Ratio
–
Last Split Date
23.04.2024
Dividend Date
–
Stock Valuation PIRS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.7644
Price Sales TTM
1.0646
Enterprise Value EBITDA
-1.4662
Price Book MRQ
1.1879
Financials PIRS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PIRS
For 52 weeks
6.2 USD
22.32 USD
50 Day MA
16.8 USD
Shares Short Prior Month
27 374
200 Day MA
13.73 USD
Short Ratio
3.63
Shares Short
26 825
Short Percent
2.53 %
BeatStart